Skip to content

Clinical trials

Completed Phase 2/3 Non-alcoholic Fatty Liver Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Phase 2/3 Status: Completed Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20071
20111
20123
20131
20142
20151
20171
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Nutrition and Food Technology Institute3
Dr Azita Hekmatdoost2
Alexion Pharmaceuticals, Inc.1
Bambino Gesù Hospital and Research Institute1
Indiana University1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Northwestern University1
Shiraz University of Medical Sciences1
University of Colorado, Denver1
University of Manitoba1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease14
Diabetes Mellitus, Type 22
Insulin Resistance2
Cholesterol Ester Storage Disease1
Fatty Liver1
Fibrosis1
Inflammation1
Liver Diseases1
Liver Diseases, Alcoholic1
Metabolic Syndrome1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.